The Prognostic Significance of Peripheral Blood Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab: A Clinical Study

Presenter Information

K. Macdougall MDFollow
M. Niazi MD
J. Hosry MD
S. Homsy MD
A. Bershadskiy MD

Facility

Staten Island University Hospital

Department

Department of Medicine

Status

Resident

Category

Clinical Science Research

Start Date

2-6-2021 12:00 AM